Cart
sales@molnova.com
m-PEG2-Br
CAS No. 54149-17-6
m-PEG2-Br( —— )
Catalog No. M26972 CAS No. 54149-17-6
m-PEG2-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product Namem-PEG2-Br
-
NoteResearch use only, not for human use.
-
Brief Descriptionm-PEG2-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Descriptionm-PEG2-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSUR2-KIR6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number54149-17-6
-
Formula Weight183.045
-
Molecular FormulaC5H11BrO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOCCOCCBr
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schwanstecher M, et al. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J. 1998 Oct 1;17(19):5529-35.
molnova catalog
related products
-
Ethyl-p-methoxycinna...
Methyl-p-couMaric acid ethyl ester is a natural product.
-
Protopine hydrochlor...
Protopine has antiplatelet effects,which is due to inhibition on thromboxane formation and phosphoinositides breakdown and then lead to the decrease of intracellular calcium concentration.
-
Tozorakimab
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting IL-33. It inhibits IL-33 signaling through ST2 and RAGE/EGFR, reduces inflammation and epithelial dysfunction, and can be used to study chronic obstructive pulmonary disease.
